GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (TSE:4967) » Definitions » Shiller PE Ratio

Kobayashi Pharmaceutical Co (TSE:4967) Shiller PE Ratio : 23.23 (As of May. 11, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Kobayashi Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-11), Kobayashi Pharmaceutical Co's current share price is 円5492.00. Kobayashi Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 was 円236.40. Kobayashi Pharmaceutical Co's Shiller PE Ratio for today is 23.23.

The historical rank and industry rank for Kobayashi Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

TSE:4967' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.97   Med: 45.73   Max: 67.8
Current: 23.23

During the past years, Kobayashi Pharmaceutical Co's highest Shiller PE Ratio was 67.80. The lowest was 20.97. And the median was 45.73.

TSE:4967's Shiller PE Ratio is ranked worse than
59.83% of 1078 companies
in the Consumer Packaged Goods industry
Industry Median: 18.98 vs TSE:4967: 23.23

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Kobayashi Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was 円64.520. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円236.40 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kobayashi Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Shiller PE Ratio Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.06 67.31 44.59 41.33 28.72

Kobayashi Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.33 36.26 34.55 28.47 28.72

Competitive Comparison of Kobayashi Pharmaceutical Co's Shiller PE Ratio

For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kobayashi Pharmaceutical Co's Shiller PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Kobayashi Pharmaceutical Co's Shiller PE Ratio falls into.



Kobayashi Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Kobayashi Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=5492.00/236.4
=23.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Kobayashi Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=64.52/106.8000*106.8000
=64.520

Current CPI (Dec. 2023) = 106.8000.

Kobayashi Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 25.125 95.700 28.039
201406 29.575 98.000 32.231
201409 37.084 98.500 40.209
201412 64.085 97.900 69.911
201503 21.809 97.900 23.792
201506 35.430 98.400 38.455
201509 38.280 98.500 41.506
201512 78.720 98.100 85.701
201603 12.910 97.900 14.084
201606 64.920 98.100 70.677
201609 36.010 98.000 39.244
201612 77.930 98.400 84.583
201703 43.810 98.100 47.695
201706 45.500 98.500 49.334
201709 59.550 98.800 64.372
201712 52.170 99.400 56.054
201803 48.340 99.200 52.043
201806 48.160 99.200 51.850
201809 77.630 99.900 82.992
201812 53.820 99.700 57.653
201903 46.650 99.700 49.972
201906 57.610 99.800 61.651
201909 89.940 100.100 95.960
201912 49.819 100.500 52.942
202003 47.890 100.300 50.994
202006 57.250 99.900 61.204
202009 90.068 99.900 96.289
202012 50.497 99.300 54.311
202103 46.420 99.900 49.626
202106 54.412 99.500 58.404
202109 89.580 100.100 95.576
202112 61.940 100.100 66.086
202203 44.870 101.100 47.400
202206 54.680 101.800 57.366
202209 87.970 103.100 91.127
202212 72.110 104.100 73.980
202303 47.430 104.400 48.520
202306 55.906 105.200 56.756
202309 100.278 106.200 100.845
202312 64.520 106.800 64.520

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kobayashi Pharmaceutical Co  (TSE:4967) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Kobayashi Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kobayashi Pharmaceutical Co (TSE:4967) Business Description

Traded in Other Exchanges
Address
KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co (TSE:4967) Headlines

No Headlines